STAT
JANUARY 13, 2025
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5
Drug Patent Watch
JANUARY 8, 2025
Drug patents are a form of intellectual property protection that grants pharmaceutical companies exclusive rights to manufacture, sell, and profit from their innovations for a set period. This exclusivity is the lifeblood of the industry, allowing companies to recoup their substantial R&D investments and fund future discoveries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JUNE 24, 2025
According to GlobalData’s Pharmaceutical Intelligence Center Deals Database, licensing agreements for innovator oligonucleotides targeting CNS indications secured a cumulative total deal value of $6.05 billion from 2021 to 2025 YTD, with ASOs contributing over half ($3.54 However, Ionis Pharmaceuticals, leads the field with $13.4
Drug Patent Watch
DECEMBER 10, 2024
By partnering with a CDMO, companies can benefit from these resources without having to invest in their own infrastructure. Collaborative Approach The regulatory process is inherently collaborative, and CDMOs work closely with pharmaceutical companies to navigate the regulatory pathway. link] UPM Pharmaceuticals.
Express Pharma
JULY 23, 2025
The biologics market is expected to grow to more than $670 billion(iv) by 2030, and for pharmaceutical companies developing these complex drugs, the BD Libertas Wearable Injector offers a customisable, patient-centric solution. 2021 May;14(3):859-869. ii) Woodley, W. Clin Transl Sci. doi.org/10.1111/cts.12946.
Express Pharma
APRIL 8, 2025
based Bionique Testing Laboratories (2021), and biologics CDMO Bionova Scientific (2022). We will contribute to the advancement of the pharmaceutical industry as a premium partner that provides innovative and reliable products and services to pharmaceutical companies.
Drug Patent Watch
DECEMBER 18, 2024
This exclusivity is the lifeblood of pharmaceutical innovation, allowing companies to recoup their massive R&D investments and incentivizing further research. According to a 2021 study by the Tufts Center for the Study of Drug Development, the average cost to develop a new drug is a staggering $2.6 billion[1].
Expert insights. Personalized for you.
Let's personalize your content